Konakion Paediatric

Phytomenadione, the active ingredient in Konakion Paediatric, is a Vitamin K presented as a sterile solution for intramuscular, intravenous, and oral use. It prevents and treats vitamin K deficiency bleeding in newborns and reverses anticoagulant effects when required, providing rapid restoration of clotting factor activity in pediatric patients.

GNH USA supplies Konakion Paediatric as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and offers reliable efficient logistics for global distribution.

Konakion Paediatric, a vitamin K preparation, acts on the coagulation cascade to correct deficiencies. - Vitamin K deficiency bleeding in newborns: prevents hemorrhagic disease by supplying essential cofactor for clotting factor activation. - Vitamin K deficiency bleeding in infants and children: treats active bleeding episodes and restores normal clotting. - Anticoagulant reversal: counteracts the effects of vitamin K antagonists such as warfarin in pediatric patients when rapid normalization of coagulation is needed.

Phytomenadione may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain - Redness or swelling at the administration site - Mild fever - Transient flushing

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hypersensitivity including rash and angioedema - Hemolysis - Thrombosis (rare)

When using Konakion Paediatric, several precautions should be observed to ensure safety. - Assess vitamin K status: verify deficiency before administration. - Hypersensitivity: avoid in patients with known allergy to phytomenadione or excipients. - Anticoagulant therapy: monitor coagulation parameters if used alongside warfarin. - Neonatal use: follow recommended prophylaxis schedule for newborns. - Concomitant medications: consider potential interactions with drugs affecting vitamin K metabolism. - Store at ambient temperature: keep in original container, protect from moisture and light.

Phytomenadione can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Warfarin: may diminish anticoagulant effect, requiring dose adjustment. - Broad‑spectrum antibiotics (e.g., cephalosporins): can reduce intestinal vitamin K synthesis, affecting response. - Bile acid sequestrants: may decrease absorption of oral phytomenadione.

Moderate Interactions (Monitor Closely): - Heparin: additive anticoagulant effect may increase bleeding risk. - Oral contraceptives: may enhance clotting factor activity, requiring monitoring. - Phenobarbital or other enzyme inducers: may increase metabolism of vitamin K, reducing efficacy.